S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
3 Top-Rated, Oversold Industry Giants
Better Than Oil Stocks? (Ad)
PayPal Keeps Getting Cheaper; Should You Load Up?
What's Really Behind The FTC's Lawsuit Targeting of Amazon?
66,000% upside on tiny biotech? (Ad)
Delta Hopes to Soar Again with Customer Loyalty Tweaks
Is the Grinch Stealing This Year's Holiday Season Jobs?
WARNING: Mandatory U.S. Dollar Recall is Weeks Away (Ad)
The Next Stage Of Google’s Rally Just Started
Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall, Friday, 9/29/2023
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
3 Top-Rated, Oversold Industry Giants
Better Than Oil Stocks? (Ad)
PayPal Keeps Getting Cheaper; Should You Load Up?
What's Really Behind The FTC's Lawsuit Targeting of Amazon?
66,000% upside on tiny biotech? (Ad)
Delta Hopes to Soar Again with Customer Loyalty Tweaks
Is the Grinch Stealing This Year's Holiday Season Jobs?
WARNING: Mandatory U.S. Dollar Recall is Weeks Away (Ad)
The Next Stage Of Google’s Rally Just Started
Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall, Friday, 9/29/2023
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
3 Top-Rated, Oversold Industry Giants
Better Than Oil Stocks? (Ad)
PayPal Keeps Getting Cheaper; Should You Load Up?
What's Really Behind The FTC's Lawsuit Targeting of Amazon?
66,000% upside on tiny biotech? (Ad)
Delta Hopes to Soar Again with Customer Loyalty Tweaks
Is the Grinch Stealing This Year's Holiday Season Jobs?
WARNING: Mandatory U.S. Dollar Recall is Weeks Away (Ad)
The Next Stage Of Google’s Rally Just Started
Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall, Friday, 9/29/2023
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
3 Top-Rated, Oversold Industry Giants
Better Than Oil Stocks? (Ad)
PayPal Keeps Getting Cheaper; Should You Load Up?
What's Really Behind The FTC's Lawsuit Targeting of Amazon?
66,000% upside on tiny biotech? (Ad)
Delta Hopes to Soar Again with Customer Loyalty Tweaks
Is the Grinch Stealing This Year's Holiday Season Jobs?
WARNING: Mandatory U.S. Dollar Recall is Weeks Away (Ad)
The Next Stage Of Google’s Rally Just Started
Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall, Friday, 9/29/2023

Crescent Capital BDC (CCAP) Stock Forecast, Price & News

$17.10
+0.11 (+0.65%)
(As of 09/29/2023 ET)
Compare
Today's Range
$16.93
$17.25
50-Day Range
$16.13
$17.43
52-Week Range
$12.55
$17.55
Volume
223,875 shs
Average Volume
115,987 shs
Market Capitalization
$633.73 million
P/E Ratio
20.12
Dividend Yield
9.59%
Price Target
$18.00

Crescent Capital BDC MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
5.3% Upside
$18.00 Price Target
Short Interest
Healthy
0.29% of Shares Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
1.62mentions of Crescent Capital BDC in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
-2.25%
From $2.22 to $2.17 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.22 out of 5 stars

Finance Sector

555th out of 854 stocks

Nondepository Credit Institutions Industry

18th out of 43 stocks


CCAP stock logo

About Crescent Capital BDC (NASDAQ:CCAP) Stock

Crescent Capital BDC, Inc. is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

CCAP Price History

CCAP Stock News Headlines

Q2 2023 Crescent Capital BDC Inc Earnings Call
Successful Options Trading Begins With…
Options trading expert Wendy Kirkland’s free guide reveals the options trading principles that are as easy to implement as they are to learn and how using them could earn you thousands in extra income each month!
This Stock Could Go Up 66% or More.
Marc Chaikin built the system that isolated NVDA before it became the best-performing stock of 2023.  Click here to get his latest buy.  More here.
Crescent Capital BDC, Inc. Provides Business Update
See More Headlines
Receive CCAP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Crescent Capital BDC and its competitors with MarketBeat's FREE daily newsletter.

CCAP Company Calendar

Last Earnings
8/09/2023
Ex-Dividend for 10/16 Dividend
9/28/2023
Ex-Dividend for 10/16 Dividend
9/28/2023
Today
9/29/2023
Dividend Payable
10/16/2023
Dividend Payable
10/16/2023
Next Earnings (Estimated)
11/08/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Nondepository credit institutions
Sub-Industry
N/A
Sector
Finance
Current Symbol
NASDAQ:CCAP
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$18.00
High Stock Price Forecast
$18.00
Low Stock Price Forecast
$18.00
Forecasted Upside/Downside
+5.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$15.54 million
Pretax Margin
47.07%

Debt

Sales & Book Value

Annual Sales
$116.72 million
Cash Flow
$1.74 per share
Book Value
$19.83 per share

Miscellaneous

Free Float
36,702,000
Market Cap
$633.73 million
Optionable
Not Optionable
Beta
0.85
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Mr. Jason A. BreauxMr. Jason A. Breaux (Age 50)
    CEO & Pres
  • Mr. Raymond F. BarriosMr. Raymond F. Barrios (Age 45)
    Managing Director
  • Mr. Gerhard LombardMr. Gerhard Lombard (Age 50)
    Chief Financial Officer
  • Daniel McMahon
    VP & Head of Public Investor Relations
  • Mr. Erik George Barrios (Age 45)
    Sr. VP, Legal Counsel & Chief Compliance Officer
  • Mr. Henry Chung
    Managing Director
  • Mr. George Pusey Hawley J.D. (Age 55)
    Sec.
  • Mr. Kirill S. BouekMr. Kirill S. Bouek (Age 39)
    Controller













CCAP Stock - Frequently Asked Questions

Should I buy or sell Crescent Capital BDC stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Crescent Capital BDC in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" CCAP shares.
View CCAP analyst ratings
or view top-rated stocks.

What is Crescent Capital BDC's stock price forecast for 2023?

3 Wall Street analysts have issued 1-year target prices for Crescent Capital BDC's stock. Their CCAP share price forecasts range from $18.00 to $18.00. On average, they anticipate the company's share price to reach $18.00 in the next year. This suggests a possible upside of 5.3% from the stock's current price.
View analysts price targets for CCAP
or view top-rated stocks among Wall Street analysts.

How have CCAP shares performed in 2023?

Crescent Capital BDC's stock was trading at $12.78 on January 1st, 2023. Since then, CCAP shares have increased by 33.8% and is now trading at $17.10.
View the best growth stocks for 2023 here
.

Are investors shorting Crescent Capital BDC?

Crescent Capital BDC saw a decline in short interest during the month of September. As of September 15th, there was short interest totaling 106,000 shares, a decline of 38.6% from the August 31st total of 172,500 shares. Based on an average daily volume of 137,400 shares, the days-to-cover ratio is currently 0.8 days.
View Crescent Capital BDC's Short Interest
.

When is Crescent Capital BDC's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 8th 2023.
View our CCAP earnings forecast
.

How were Crescent Capital BDC's earnings last quarter?

Crescent Capital BDC, Inc. (NASDAQ:CCAP) announced its quarterly earnings results on Wednesday, August, 9th. The company reported $0.56 earnings per share for the quarter, beating the consensus estimate of $0.54 by $0.02. The business earned $46.74 million during the quarter, compared to analyst estimates of $45.71 million. Crescent Capital BDC had a net margin of 20.44% and a trailing twelve-month return on equity of 9.86%.

How often does Crescent Capital BDC pay dividends? What is the dividend yield for Crescent Capital BDC?

Crescent Capital BDC declared a quarterly dividend on Thursday, September 28th. Shareholders of record on Friday, September 29th will be paid a dividend of $0.08 per share on Monday, October 16th. This represents a $0.32 annualized dividend and a dividend yield of 1.87%. The ex-dividend date is Thursday, September 28th. This is a positive change from the stock's previous quarterly dividend of $0.05.
Read our dividend analysis for CCAP
.

What ETFs hold Crescent Capital BDC's stock?

ETFs with the largest weight of Crescent Capital BDC (NASDAQ:CCAP) stock in their portfolio include Putnam BDC Income ETF (PBDC).Virtus Private Credit ETF (VPC).

Is Crescent Capital BDC a good dividend stock?

Crescent Capital BDC (NASDAQ:CCAP) pays an annual dividend of $1.64 per share and currently has a dividend yield of 9.44%. CCAP has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 192.94%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, CCAP will have a dividend payout ratio of 75.58% in the coming year. This indicates that the company may not be able to sustain their current dividend.
Read our dividend analysis for CCAP.

What other stocks do shareholders of Crescent Capital BDC own?
What is Crescent Capital BDC's stock symbol?

Crescent Capital BDC trades on the NASDAQ under the ticker symbol "CCAP."

How do I buy shares of Crescent Capital BDC?

Shares of CCAP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Crescent Capital BDC's stock price today?

One share of CCAP stock can currently be purchased for approximately $17.10.

How much money does Crescent Capital BDC make?

Crescent Capital BDC (NASDAQ:CCAP) has a market capitalization of $633.73 million and generates $116.72 million in revenue each year. The company earns $15.54 million in net income (profit) each year or $0.85 on an earnings per share basis.

How can I contact Crescent Capital BDC?

Crescent Capital BDC's mailing address is 11100 SANTA MONICA BLVD.SUITE 2000, LOS ANGELES CA, 90025. The official website for the company is www.crescentbdc.com. The company can be reached via phone at 310-235-5900 or via email at bdcir@crescentcap.com.

This page (NASDAQ:CCAP) was last updated on 9/30/2023 by MarketBeat.com Staff

My Account -